Sometimes the biggest clue is not in the blood work. This clip explains why chronic infections, mold exposure, pesticides, contaminated water, and other environmental factors should be considered when symptoms refuse to improve. Looking at when symptoms started, what makes them better or worse, and what someone is exposed to every day can reveal problems that standard testing may miss.

Some mold and chronic inflammatory response patients are already using transcriptomic testing to see which inflammatory genes are actively being expressed. This clip explains how tools such as GENIE may help track whether a treatment is actually changing biology in real time, potentially offering more useful information than a static genetic test.

Functional testing looks beyond how much of a nutrient is floating in your blood and asks whether that nutrient is actually doing its job inside the cell. This clip explains how enzyme activity and metabolic byproducts can reveal where key biochemical processes are slowing down, and how those patterns can point toward missing nutrient co-factors.

Orthomolecular medicine starts with a different question: could chronic disease be driven by problems in how the body uses nutrients? This clip explains how vitamins, minerals, and nutrient co-factors fit into this model, and how it differs from a pharmaceutical approach focused primarily on managing symptoms or altering biochemical pathways with drugs.

Mold exposure may interfere with thiamine in more than one way. This clip explores how certain mycotoxins may directly affect B1, while mold-related neuroinflammation can also disrupt thiamine chemistry downstream. It also looks at reports of improved brain function from lipid-soluble thiamine derivatives, even in people still dealing with mold exposure.

Thiamine information is scattered across studies, videos, articles, and forums, which makes it difficult to know where to start. This clip introduces EONutrition’s Thiamine Wiki, a centralized resource designed to combine technical research with clear, practical explanations, plus guidance for people who experience unusual symptoms when starting B1.

High-dose thiamine is not always about correcting a simple dietary deficiency. This clip explains how very large doses may help reactivate thiamine-dependent enzymes that have become blocked or impaired, allowing cells to produce energy more effectively. The discussion also points to traumatic brain injury research showing how restoring B1-dependent energy pathways may reduce secondary cellular damage.

A normal thiamine blood test does not necessarily mean your cells have enough B1. This clip explains why serum and plasma thiamine mainly reflect what is circulating in the blood recently, not what is actually happening inside your cells, and why relying on those results alone can create a false sense of security.

High-dose thiamine can sometimes help dramatically at first, then start producing completely different symptoms later. This clip explains why people correcting a B1 deficiency may eventually need to reduce the dose, especially if signs of sympathetic nervous system overdrive begin appearing after months of improvement.

This clip explains why lithium orotate is recommended as a low-dose form of lithium and why 1 mg is presented as a baseline amount based on evolutionary intake. The discussion also looks at orotate’s role as a carrier, including how it may interact with transport systems in the gut, cells, and blood-brain barrier.